HeimRKDA • NASDAQ
add
Arcadia Biosciences Inc
Við síðustu lokun
3,48 $
Dagbil
3,35 $ - 3,51 $
Árabil
1,87 $ - 10,31 $
Markaðsvirði
4,64 m. USD
Meðalmagn
5,72 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 1,54 m. | 18,41% |
Rekstrarkostnaður | 2,24 m. | 20,32% |
Nettótekjur | -1,61 m. | 37,20% |
Hagnaðarhlutfall | -104,88 | 46,97% |
Hagnaður á hvern hlut | -0,87 | — |
EBITDA | -1,75 m. | -34,02% |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 6,58 m. | -58,11% |
Heildareignir | 15,24 m. | -35,05% |
Heildarskuldir | 5,09 m. | -36,89% |
Eigið fé alls | 10,15 m. | — |
Útistandandi hlutabréf | 1,36 m. | — |
Eiginfjárgengi | 0,46 | — |
Arðsemi eigna | -26,99% | — |
Ávöxtun eigin fjár | -38,88% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -1,61 m. | 37,20% |
Handbært fé frá rekstri | -1,75 m. | 39,27% |
Reiðufé frá fjárfestingum | 180,00 þ. | 3.500,00% |
Reiðufé frá fjármögnun | 4,00 þ. | -42,86% |
Breyting á handbæru fé | -1,57 m. | 45,42% |
Frjálst peningaflæði | 3,25 m. | 6.857,40% |
Um
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought. Wikipedia
Stofnsett
2002
Höfuðstöðvar
Vefsvæði
Starfsfólk
21
